AI could revolutionize ambulance care by providing real-time patient assessment

Assessing how seriously injured a person is, involves weighing up lots of different parameters fast. If healthcare professionals could get support making fast-paced, life-critical decisions from an AI tool, more lives could be saved.

AbbVie drops two early-stage ADCs, including Pfizer-partnered oncology program

AbbVie removed two early-stage antibody-drug conjugates from its pipeline, per a Wednesday update to its pipeline webpage. The Chicago-area Big Pharma culled ABBV-011 and the

August 25, 2023

Inside the looming crisis in the infant formula market

Danielle and Andrew West spent their first month as parents praying their child would live. Their son Owen, born six weeks early in November 2015,

January 21, 2025

Gene Therapy for Hemophilia Becomes a Reality

Earlier this year we reported on FDA’s approval of valoctocogene roxaparvovec (Roctavian) for adults with severe hemophilia A. In this story, we provide an update

December 30, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.